hexavac
sanofi pasteur msd, snc - purified diphtheria toxoid, purified tetanus toxoid, purified pertussis toxoid, purified pertussis filamentous haemagglutinin, hepatitis b surface antigen, inactivated type 1 poliovirus (mahoney), inactivated type 2 poliovirus (mef 1), inactivated type 3 poliovirus (saukett), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines - this combined vaccine is indicated for primary and booster vaccination of children against diphtheria, tetanus, pertussis, hepatitis b caused by all known subtypes of viruses, poliomyelitis and invasive infections caused by haemophilus influenzae type b.
procomvax
sanofi pasteur msd, snc - polyribosylribitol phosphate from haemophilus influenzae type b as prp-ompc, outer membrane protein complex of neisseria meningitidis (outer membrane protein complex of the b11 strain of neisseria meningitidis subgroup b), adsorbed hepatitis b surface antigen produced in recombinant yeast cells (saccharomyces cerevisiae) - hepatitis b; meningitis, haemophilus; immunization - vaccines - procomvax is indicated for vaccination against invasive disease caused by haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis b virus in infants 6 weeks to 15 months of age.,
avaxim inactivated hepatitis a vaccine 160 d-ant. %v/v solution for injection
sanofi pasteur msd ltd - hepatit a virus antigen - solution for injection - 160 d-ant. %v/v - hepatitis vaccines
viatim suspension for injection
sanofi pasteur msd ltd - vi polysaccharide of salmonella typhi, hepatit a virus antigen - suspension for injection - bacterial and viral vaccines, combined
humenza
sanofi pasteur s.a. - split influenza virus, inactivated, containing antigen*: a/california/7/2009 (h1n1)v like strain (x-179a)*propagated in eggs. - influenza, human; immunization; disease outbreaks - vaccines - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.
pneumovax 25mcg/0.5m %v/v solution for injection
sanofi pasteur msd ltd - pneumococcal vaccine - solution for injection - 25mcg/0.5m %v/v - pneumococcal vaccines
poliomyelitis vaccine %v/v suspension for injection
sanofi pasteur msd ltd - polio virus type 1 inactivated, polio virus type 2 inactivated, polio virus type 3 inactivated - suspension for injection - %v/v - poliomyelitis vaccines
rabies vaccine pasteur merieux 2.5 iu/ml suspension for injection
sanofi pasteur msd ltd - rabies vaccine - suspension for injection - 2.5 iu/ml - rabies vaccines
stamaril yellow fever vaccine 1000 suspension for injection
sanofi pasteur msd ltd - yellow fever virus 17 d-204 strain - suspension for injection - 1000 - yellow fever vaccines
tetravac 0 suspension for injection
sanofi pasteur msd ltd - purified tetanus toxoid, purified diphtheria toxoid ph. eur., adsorbed purified pertussis toxoid, adsorbed purified filamentous haemagglutinin, inactivated poliomyelitis virus ph. eur, inactivated type 1 poliovirus, inactivated type 2 poliovirus, inactivated type 3 poliovirus - suspension for injection - bacterial and viral vaccines, combined